| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |